Набор данных из Zenodo · Sirsat, Nitin
Global Dry Eye Syndrome Treatment Market 2024 To 2033
- Лицензия
- CC BY 4.0можно в коммерцииТекст лицензии
- Лицензия разрешает коммерческое использование. Обычно нужно указать автора — точные условия в тексте лицензии.
- Форматы
- CSV
- Размер
- 665 Б
- Обновлён
- 3 янв. 2025 г.
Описание
Dry Eye Syndrome Treatment Market Size, Trends and Insights By Type (Evaporative Dry Eye Syndrome, Aqueous Deficient Dry Eye Syndrome), By Drug (Restasis, Xiidra, Cequa, Eysuvis, Tyrvaya, Others), By Product (Cyclosporine, Topical Corticosteroids, Artificial Tears, Punctal Plugs, Oral Omega Supplements, Others), By Dosage Form (Gels, Eye Solutions, Capsules & Tablets, Eye Drops, Ointments, Others), By Sales Channel (Prescription, OTC), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Others), and By Region - Global Industry Overview, Statistical Data, Competitive Analysis, Share, Outlook, and Forecast 2024–2033. Reports Description As per the current market research conducted by the CMI Team, the global Dry Eye Syndrome Treatment Market is expected to record a CAGR of 7.1% from 2024 to 2033. In 2024, the market size is projected to reach a valuation of USD 6,605.8 Million . By 2033, the valuation is anticipated to reach USD 12,281.4 Million . The dry eye syndrome treatment market encompasses pharmaceuticals, devices, and therapies aimed at alleviating symptoms and addressing the underlying causes of dry eye. With a growing global prevalence…
Описание из Zenodo, сокращённое.
Файлы (1)
DataHunter не хранит и не раздаёт эти файлы: каждая ссылка ведёт к первоисточнику. Перед использованием проверьте там лицензию.